Picture of Abionyx Pharma SA logo

ABNX — Abionyx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Cerenis Therapeutics Holding Completes Capital Increase Of 1.1 Million Euros

July 26 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * FINANCING FROM INVESTMENT FUNDS, MANAGEMENT, ITS BOARD OF
DIRECTORS AND ITS ONCOLOGY SCIENTIFIC ADVISORY BOARD
    * ISSUES TODAY 638,753 NEW SHARES AT A PRICE OF EUR 1.78 PER
SHARE
    * CAPITAL INCREASE OF MORE THAN ONE MILLION EUROS FOR THE
FINANCING OF ITS IMMUNO-ONCOLOGY ACTIVITIES
    * ISSUING 638,753 NEW SHARES AT A PRICE OF 1.78 EUROS PER
SHARE
    * TOTAL AMOUNT OF THE CAPITAL INCREASE IS 1.1 MLN EUROS
    * AFTER CAPITAL INCREASE, NUMBER OF SHARES WILL AMOUNT TO
18,947,016

Source text for Eikon:  urn:newsml:reuters.com:*:nBw71zKzWa
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Abionyx Pharma SA

See all news